Hyperliquid Strategies expanded its equity financing facility with Chardan Capital Markets from $1 billion to $2.5 billion, allowing it to sell more shares over time to fund general corporate purposes, including potential purchases of its native token, HYPE. The facility does not guarantee the full amount will be raised and includes a cap on shares sold below $12.02 after the first $1 billion. This move provides flexibility for Hyperliquid to raise capital without incurring debt but may dilute existing shareholders. The company’s stock closed below the price cap, which could limit share sales at lower prices unless shareholders approve exceptions or prices rise.
Evotec SE and Plectonic Biotech have launched a research collaboration to develop a novel immunotherapy for solid tumors by combining Evotec's BiTco platform with Plectonic's LOGIBODY® technology. This partnership aims to overcome challenges in T cel...
Ethereum surged 32.5% in August, its strongest monthly gain since July 2025, fueled by $1.85 billion net inflows into US spot Ethereum ETFs and large holders accumulating 430,000 ETH. Smaller investors reduced holdings while staking participation gre...
Broadridge Financial Solutions has expanded its Distributed Ledger Repo (DLR) solution to include G7 securities, enabling global cross-border repo transactions and collateral movements with atomic settlement. This expansion allows institutions to exe...
Cryptocurrency markets fell amid rising US-Iran tensions, with Solana and Tron dropping over 3%, while Bitcoin showed resilience, declining only about 1% near $77,500. The broader sell-off was driven by global macroeconomic concerns, including rising...
Bitcoin has remained stable around the $76,000-$80,000 range despite challenges from rising oil prices, higher U.S. Treasury yields, and falling equities. These factors typically pressure risk assets, but Bitcoin's resilience may be due to increased ...
